IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cascadian Therapeutics Inc

CUSIP: 14740B906 | 3 institutional holders

Quarters

Q4 2017Q3 2017Q2 2017Q1 2017Q4 2016
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile